Cortene
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2811 Hillside Dr, Burlingame, California...Phone Number
(650) 281-7117Website
www.corteneinc.comRevenue
<$5 MillionIndustry
About Cortene
Is Cortene your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Cortene, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Cortene had a recent Job posting/layoffs
Check if Cortene has recently received funding, and reach out quickly before it becomes old news!
Check out if Cortene is spiking on competitors!
Funding: Get notified immidiatlly once Cortene has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Cortene launches new products
Earning: See what the market has to say on Cortene recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Cortene
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Cortene
Find 2 more new buyers
Compare Similar Companies to Cortene
Compare insights from companies similar to Cortene, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cortene
Company Profile Activity
Activity Insights
Cortene is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cortene is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cortene.
Cortene Tech Stack
A closer look at the technologies used by Cortene
Cortene News & Media
Clinical trial provides preliminary evidence of a cure for myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) and Long Covid
BURLINGAME, Calif., Sept. 2, 2021 /PRNewswire/ -- Cortene Inc. announces publication of its InTiME clinical trial in which a short subcutaneous infusion of its experimental drug, CT38, achieved sustained symptom improvement in ME/CFS. The company intends to test CT38 in Long Covid, the...
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cortene
Cortene is focused on developing a patent-protected, peptide-based treatment aimed at addressing brain-centric acquired chronic diseases (ACDs). Their innovative approach seeks to restore normal brain signals that may become dysregulated, potentially curing conditions such as Parkinson's, Alzheimer's, and chronic fatigue syndrome. The company targe... Read More